Pancreatic Cancer Research

ResearcherSoochow UniversityActive in the last 2 years

Yong Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8087-5717; OpenAlex author ID A5016655840. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. circMTHFD1L-driven lipid metabolism in Cancer-associated fibroblasts confers oxaliplatin resistance in pancreatic cancer through O-GlcNAcylation-dependent chro… Co-author DOI 10.1016/j.canlet.2026.218863↗
  2. Liver diseases, transaminases, and hepatobiliary-pancreatic cancer risk: a cohort and Mendelian randomisation study using data from UK Biobank. First author DOI 10.1136/bmjgast-2025-001870↗
  3. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration. Last author DOI 10.3389/fgene.2022.1022626↗
  4. Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients. Last author DOI 10.1038/s41392-020-00260-1↗
  5. MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS. Co-author DOI 10.5114/aoms.2018.72564↗
  6. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer. Co-author DOI 10.18632/oncotarget.16462↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huimou Chen · 2 shared papers, 2025–2026 · strength 0.46
  2. Shangyou Zheng · 2 shared papers, 2025–2026 · strength 0.46
  3. Rihua He · 2 shared papers, 2025–2026 · strength 0.46
  4. Tian Qing · 1 shared paper, 2026 · strength 0.25
  5. Tianhao Huang · 1 shared paper, 2026 · strength 0.25
  6. Rufu Chen · 1 shared paper, 2026 · strength 0.25
  7. Chonghui Hu · 1 shared paper, 2026 · strength 0.25
  8. Rufu Chen · 1 shared paper, 2025 · strength 0.21
  9. Yuan Yuan · 1 shared paper, 2025 · strength 0.21
  10. Chengyuan Hu · 1 shared paper, 2025 · strength 0.21
  11. Jieyan Wang · 1 shared paper, 2022 · strength 0.15
  12. Xuemin Chen · 2 shared papers, 2017–2018 · strength 0.15
  13. Yong An · 2 shared papers, 2017–2018 · strength 0.15
  14. Huihua Cai · 2 shared papers, 2017–2018 · strength 0.15
  15. Mao Lin · 1 shared paper, 2020 · strength 0.11
  16. Jibing Chen · 1 shared paper, 2020 · strength 0.11
  17. Xiaoyan Zhang · 1 shared paper, 2020 · strength 0.11
  18. Mohammed Alnaggar · 1 shared paper, 2020 · strength 0.11
  19. Lizhi Niu · 1 shared paper, 2020 · strength 0.11
  20. Baoqiang Wu · 1 shared paper, 2018 · strength 0.08
  21. Xinquan Wu · 1 shared paper, 2018 · strength 0.08
  22. B Y Luo · 1 shared paper, 2017 · strength 0.06
  23. Di Wu · 1 shared paper, 2017 · strength 0.06
  24. Yong Yang · 1 shared paper, 2017 · strength 0.06
  25. Xiaozhou He · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.